Politician trade (House)

Eli Lilly (LLY): Rep. David J. Taylor (OH02) disclosed a sale $1K–$15K

Rep. David J. Taylor (OH02) disclosed a sale of Eli Lilly in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
11 days
Disclosure lag
Traded
Feb 9, 2026
Disclosed
Feb 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 13, 2025CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  2. Nov 18, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  3. Dec 10, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  4. Dec 18, 2025CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  5. Dec 19, 2025FDAFDA drug approval: Mounjaro
  6. Dec 23, 2025Insider10% owner sold ~$260K of LLY shares in the open market
  7. Dec 24, 2025Insider10% owner sold ~$2.85M of LLY shares in the open market
  8. Dec 29, 2025Insider10% owner sold ~$3.9M of LLY shares in the open market
  9. Dec 29, 2025Congress · 2 peopleMembers of Congress: 2 purchases
  10. Jan 5, 2026Insider10% owner sold ~$1.51M of LLY shares in the open market
  11. Jan 7, 2026Insider · 1 personInsiders: 30 sales (~$322.4M)
  12. Jan 16, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  13. Jan 23, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.8%
  14. Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
  15. Feb 9, 2026 · this disclosureCongressDisclosed sale of LLY — reported range $1,001 - $15,000

What came next

  1. Feb 13, 2026CongressDisclosed sale of LLY — reported range $1,001 - $15,000
  2. Feb 26, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  3. Mar 13, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  4. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  5. Apr 1, 2026FDAFDA drug approval: Foundayo
  6. Apr 2, 2026Congress · 1 personMembers of Congress: 2 purchases
  7. Apr 8, 2026CongressDisclosed partial sale of LLY — reported range $1,001 - $15,000
  8. Apr 14, 2026CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  9. Apr 20, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.7%
  10. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
  11. May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.5%
  12. May 6, 2026Insider · 1 personInsiders: 2 sales (~$15.8M)
  13. May 15, 2026Federal contract · $52K obligatedDepartment of Veterans Affairs awarded Eli Lilly: $52K obligated to date
  14. Jun 9, 2026FDAFDA drug approval: Ebglyss
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by Rep. David J. Taylor (OH02)

The full history of Rep. David J. Taylor (OH02) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Eli Lilly (LLY) stock, and how much?

Rep. David J. Taylor (OH02) disclosed a sale of Eli Lilly in the $1K–$15K range. Reported range, not an exact amount.

When did it happen, and when was it made public?

Traded: Feb 9, 2026. Disclosed: Feb 20, 2026. That is 11 days between the two dates.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Eli Lilly recently?

For Eli Lilly, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the LLY page.

Does this mean LLY stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Eli Lilly

Everything OQRO holds on this company is on its LLY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data